Elsevier

Metabolism

Volume 43, Issue 3, March 1994, Pages 279-284
Metabolism

Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: Relationship to endogenous glucose production and peripheral tissue glucose uptake

https://doi.org/10.1016/0026-0495(94)90093-0Get rights and content

Abstract

This study was performed to characterize and compare the actions of insulin on hepatic glucose production and peripheral glucose utilization during infusions of endotoxin, tumor necrosis factor (TNF), interleukin-1 (IL-1), and a combination of IL-1 and TNF in the rat. The euglycemic hyperinsulinemic clamp technique was combined with a primed-constant tracer infusion of high-performance liquid chromatography (HPLC)-purified 3H-3-glucose for estimation of whole-body glucose appearance and utilization rates; 14C-deoxyglucose (14C-DG) uptake was also measured in specific tissues following intravenous bolus administration. As expected, acute endotoxemia resulted in a significant reduction of glucose infusion during the clamp procedure (insulin concentration, 100 μU/mL), suggesting decreased insulin action. Similarly, infusion of TNF decreased the rate of glucose infusion necessary to maintain euglycemia. However, differences between endotoxin- and cytokine-treated rats were noted in whole-body glucose appearance (or disappearance) rates. Whereas endotoxin infusion predominantly decreased whole-body glucose uptake, suggesting diminished utilization in skeletal muscles, cytokine infusions were associated with a measurable hepatic glucose output despite hyperinsulinemia. In contrast, both cytokine and endotoxin administration decreased the rate of 14C-DG uptake by muscle tissue. These results demonstrate that TNF, IL-1, and endotoxin can induce a state of insulin resistance when infused continuously; the results also emphasize the complexity of regulation of glucose homeostasis during infection and sepsis.

References (32)

  • TV Zenser et al.

    Infection-induced hyperglucagonemia and altered hepatic response to glucagon in the rat

    Am J Physiol

    (1974)
  • EE Tredget et al.

    Role of interleukin 1 and tumor necrosis factor in energy metabolism in rabbits

    Am J Physiol

    (1988)
  • A Del Rey et al.

    Interleukin 1 affects glucose homeostasis

    Am J Physiol

    (1987)
  • EA Flores et al.

    Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat: A synergistic effect with interleukin 1

    J Clin Invest

    (1989)
  • RA DeFronzo et al.

    Glucose clamp technique: A method for quantifying insulin secretion and resistance

    Am J Physiol

    (1979)
  • L Sokoloff et al.

    The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat

    J Neurochem

    (1977)
  • Cited by (107)

    • Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes

      2022, Translational Research
      Citation Excerpt :

      Chronic inflammation is a plausible biological mechanism linking infections and insulin resistance. Animal models have shown that inflammatory cytokines such as TNF-α can induce a state of insulin resistance,47 possibly as a consequence of TNF-α’s ability to interrupt serine phosphorylation of IRS-1,48 and data in humans have repeatedly shown inflammation to be an independent risk factor for both insulin resistance49 and T2DM.50-52 If a chronic inflammatory phenotype emerges in some COVID-19 patients, it is plausible that insulin resistance may follow along with increased risk for incident prediabetes of diabetes.

    • Foundations of Immunometabolism and Implications for Metabolic Health and Disease

      2017, Immunity
      Citation Excerpt :

      Soon after, similar observations showed increased TNF expression in the adipose tissue of obese humans, as reported by two simultaneous and independent publications (Hotamisligil et al., 1995; Kern et al., 1995), and subsequently it was shown that TNF expression was also elevated in the muscle tissue of obese humans (Saghizadeh et al., 1996). Many groups also demonstrated that neutralization of TNF in obese rats or mice resulted in increased insulin sensitivity and improved glucose metabolism (Borst and Bagby, 2002; Hotamisligil et al., 1993; Liang et al., 2008) (for a complete list, see https://www.metaflammation.org/), whereas publications from the Grunfeld group, Jerry Olefsky’s group, and Nawfal Istafan and colleagues all showed that administration of TNF caused insulin resistance and impaired glucose metabolism in animal models (Feingold et al., 1989; Ling et al., 1994; Miles et al., 1997). These studies identified differences in glucose fluxes between acute and chronic TNF exposures, as well as the target tissues responsible for impaired insulin action, increased glucose production, and alterations in disposal.

    View all citing articles on Scopus

    Supported in part by Grants No. CA 45768, DK 40492, DK 31933, and DK 41128 from the National Institutes of Health.

    View full text